Compliance certificate under Reg. 74(5) of SEBI (DP) 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Ltd has submitted a routine compliance certificate to BSE under SEBI's Regulation 74(5) for the quarter ended September 30, 2025. The certificate, issued by the company's Registrar and Share Transfer Agent (Bigshare Services Private Limited), confirms that no dematerialisation requests for equity shares were received between July 1, 2025 and September 30, 2025. The filing was signed by Adarsh Munjal, Whole Time Director of the company. Note: The document identifies the company as Remedium Lifecare Ltd, though the filing reference mentions Supha Pharmachem Ltd.
This is a standard regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that no physical share certificates were converted into demat form during the quarter, indicating routine operational compliance.